isofuranodiene has been researched along with Breast Cancer in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buccioni, M; Dal Ben, D; Lambertucci, C; Maggi, F; Marucci, G; Papa, F; Santinelli, C; Thomas, A | 1 |
| Chen, X; Kong, Q; Ma, Y; Yu, J | 1 |
| Guo, DW; Lao, QC; Li, CQ; Li, P; Meng, ZK; Xia, B; Xu, YQ; Yang, H; Zhu, XY | 1 |
| Chen, X; Tan, W; Wang, Y; Zhong, Z | 1 |
| Qiang, WA; Tan, W; Wang, CM; Wang, YT; Zhong, ZF | 1 |
| Qiang, WA; Tan, W; Tian, K; Wang, YT; Yu, H; Zhong, ZF | 1 |
| Lin, DH; Sun, XY; Yuan, CS; Zhang, H; Zhao, F; Zheng, YP | 1 |
| Chen, MW; Chen, XP; Li, YB; Tan, W; Wang, SP; Wang, YT; Zhong, ZF | 1 |
| Chen, X; Cui, J; Dang, Y; Guo, W; Li, Y; Lu, J; Tan, W; Wang, Y; Yuan, X; Zhang, Q; Zhong, Z | 1 |
9 other study(ies) available for isofuranodiene and Breast Cancer
| Article | Year |
|---|---|
Antiproliferative evaluation of isofuranodiene on breast and prostate cancer cell lines.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Female; Furans; Humans; Male; Prostatic Neoplasms; Time Factors | 2014 |
Predicted molecular targets and pathways for germacrone, curdione, and furanodiene in the treatment of breast cancer using a bioinformatics approach.
Topics: Breast Neoplasms; Computational Biology; Drugs, Chinese Herbal; Female; Furans; Heterocyclic Compounds, 2-Ring; Humans; MCF-7 Cells; Medicine, Chinese Traditional; Molecular Targeted Therapy; Sesquiterpenes, Germacrane | 2017 |
Sensitization and synergistic anti-cancer effects of Furanodiene identified in zebrafish models.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Female; Furans; Heterocyclic Compounds, 2-Ring; Humans; Lung Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zebrafish | 2019 |
Furanodiene, a natural small molecule suppresses metastatic breast cancer cell migration and invasion in vitro.
Topics: Antineoplastic Agents; Biological Products; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Furans; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 2-Ring; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Metastasis; Tetradecanoylphorbol Acetate | 2014 |
Furanodiene enhances the anti-cancer effects of doxorubicin on ERĪ±-negative breast cancer cells in vitro.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Breast; Breast Neoplasms; Doxorubicin; Drug Synergism; Epithelial Cells; Estrogen Receptor alpha; Furans; Gene Expression Regulation, Neoplastic; Hepatocytes; Heterocyclic Compounds, 2-Ring; Humans; Macrophages; MCF-7 Cells; Myoblasts; Pheochromocytoma; Reactive Oxygen Species | 2016 |
Combined effects of furanodiene and doxorubicin on the migration and invasion of MDA-MB-231 breast cancer cells in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Curcuma; Doxorubicin; Female; Focal Adhesion Kinase 1; Furans; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 2-Ring; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Proteins; Plant Extracts; Signal Transduction | 2017 |
Potential anti-cancer activities of Furanodiene, a Sesquiterpene from Curcuma wenyujin.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Division; Curcuma; Drugs, Chinese Herbal; Female; Fibrosarcoma; Furans; HeLa Cells; Heterocyclic Compounds, 2-Ring; HL-60 Cells; Humans; K562 Cells; Leukemia; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred Strains; Organ Size; Sesquiterpenes; Spleen; Thymus Gland; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2009 |
Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPARĪ³ independent manner.
Topics: Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; DNA Fragmentation; Electrophoresis, Agar Gel; Furans; Heterocyclic Compounds, 2-Ring; Humans; Immunoprecipitation; PPAR gamma; Tamoxifen | 2012 |
Furanodiene, a natural product, inhibits breast cancer growth both in vitro and in vivo.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; Breast Neoplasms; Caspase 7; Caspase 9; Cell Line, Tumor; Cell Proliferation; Curcuma; DNA Fragmentation; Female; Furans; G1 Phase Cell Cycle Checkpoints; Heterocyclic Compounds, 2-Ring; Humans; L-Lactate Dehydrogenase; MCF-7 Cells; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Transplantation, Heterologous | 2012 |